Mapatumumab/sorafenib combination is safe in patients with advanced HCC and chronic hepatitis Jan. 26, 2011
Combination therapies including cediranib well tolerated in patients with gastric cancer Jan. 24, 2011
Crizotinib suppresses osteosarcoma and associated osteolytic/osteoblastic changes in vivo Jan. 24, 2011
RSS